Technical Analysis for SBTX - Skinbiotherapeutics Plc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| MACD Bearish Centerline Cross | Bearish | -2.70% | |
| Narrow Range Bar | Range Contraction | -2.70% | |
| Inside Day | Range Contraction | -2.70% | |
| Wide Bands | Range Expansion | -2.70% | |
| Oversold Stochastic | Weakness | -2.70% | |
| Fell Below 50 DMA | Bearish | -2.70% | |
| Narrow Range Bar | Range Contraction | -2.70% | |
| Wide Bands | Range Expansion | -2.70% | |
| Gapped Down | Weakness | -2.70% | |
| Oversold Stochastic | Weakness | -2.70% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | about 3 hours ago |
| Outside Day | about 3 hours ago |
| Up 2% | about 3 hours ago |
| Up 1% | about 3 hours ago |
| Fell Below Previous Day's Low | about 4 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
SkinBioTherapeutics PLC is a life science company focused on skin health. The Company’s platform technology, SkinBiotix, applies research discoveries made on the activities of lysates derived from probiotic bacteria when applied to skin. The Company’s SkinBiotix platform can improve the barrier effect of skin models, improve repair and reduce bacterial load. It focuses on three specific skin healthcare sectors: cosmetics, infection control and eczema. In each of these areas, the Company plans to exemplify its technology in human studies. The Company’s program is focused on the application of the Skinbiotix platform in managing sensitive skin in the cosmetics industry. SkinBiotix increases the rate of skin healing in response to injury.
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Healthcare Science Branches Of Biology Skin Infection Cosmetics Healthcare Sector Skin Care Platform Technology Healthcare Sectors Soft Tissue Bacteria Injury Dermatitis Infection Control
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Healthcare Science Branches Of Biology Skin Infection Cosmetics Healthcare Sector Skin Care Platform Technology Healthcare Sectors Soft Tissue Bacteria Injury Dermatitis Infection Control
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 29.5 |
| 52 Week Low | 7.0 |
| Average Volume | 819,997 |
| 200-Day Moving Average | 16.43 |
| 50-Day Moving Average | 9.55 |
| 20-Day Moving Average | 10.10 |
| 10-Day Moving Average | 9.65 |
| Average True Range | 0.93 |
| RSI (14) | 45.05 |
| ADX | 19.18 |
| +DI | 21.20 |
| -DI | 19.87 |
| Chandelier Exit (Long, 3 ATRs) | 11.41 |
| Chandelier Exit (Short, 3 ATRs) | 9.79 |
| Upper Bollinger Bands | 12.28 |
| Lower Bollinger Band | 7.91 |
| Percent B (%b) | 0.31 |
| BandWidth | 43.29 |
| MACD Line | -0.03 |
| MACD Signal Line | 0.05 |
| MACD Histogram | -0.0848 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 9.78 | ||||
| Resistance 3 (R3) | 9.79 | 9.63 | 9.70 | ||
| Resistance 2 (R2) | 9.63 | 9.49 | 9.62 | 9.67 | |
| Resistance 1 (R1) | 9.44 | 9.41 | 9.43 | 9.43 | 9.64 |
| Pivot Point | 9.27 | 9.27 | 9.27 | 9.27 | 9.27 |
| Support 1 (S1) | 9.08 | 9.14 | 9.07 | 9.07 | 8.86 |
| Support 2 (S2) | 8.92 | 9.05 | 8.91 | 8.83 | |
| Support 3 (S3) | 8.73 | 8.92 | 8.80 | ||
| Support 4 (S4) | 8.72 |
